NTRK

Clinical trials for NTRK explained in plain language.

Never miss a new study

Get alerted when new NTRK trials appear

Sign up with your email to follow new studies for NTRK, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New pill targets rare gene mutations in Hard-to-Treat cancers

Disease control Recruiting now

This early-stage study tests an experimental drug, CG001419, in adults with advanced solid tumors that have specific NTRK gene changes. The goal is to find a safe dose and see if the drug can shrink tumors. About 42 participants will take the drug by mouth until their disease get…

Matched conditions: NTRK

Phase: PHASE1, PHASE2 • Sponsor: Cullgen (Shanghai),Inc • Aim: Disease control

Last updated May 15, 2026 11:55 UTC

NTRK

Get alerted when new NTRK trials appear

New pill targets rare gene mutations in Hard-to-Treat cancers